Nanomedicine News

RSS

Biodegradable Nano 'Drones' Could Prevent Heart Attacks Caused By Atherosclerosis

Nanometer-sized "drones" that deliver a special type of healing molecule to fat deposits in arteries could become a new way to prevent heart attacks caused by atherosclerosis, according to a study in pre-clinical models by scientists at Brigham and Women's Hospital (BWH) and Columbia University Medical Center. These findings are published in the February 18th online issue of Science Translational Medicine.

19 Feb 2015

Antimicrobial Silver Nanoparticles Induce Stress in the Endoplasmic Reticulum, Demonstrating Nanotoxicity

Whereas resistance to antibiotics complicates certain treatments, antimicrobial silver nanoparticles (AgNP) are gaining popularity for medical use. These particles are toxic for certain bacteria, but what about for humans? Researchers at INRS-Institut Armand-Frappier Research Centre have taken a step toward understanding the cellular and molecular mechanisms that affect these particles.

19 Feb 2015

Conventional Patch-Clamp Technique Combined with AFM Helps Record Activity of Moving Cells

Electrical impulses play an important role in cells of the human body. For example, neurons use these impulses to transmit information along their branches and the body also uses them to control the contraction of muscles.

18 Feb 2015

NanoGap Sensor Device for Early Detection of Bladder and Kidney Cancer

A new mobile device that allows bladder and kidney cancer to be detected at an early stage. This is being worked on by Wilfred van der Wiel, professor of nanoelectronics at the University of Twente MESA+ research institute. Thanks to this method, it is possible to read from DNA cells whether their carrier has bladder or kidney cancer.

16 Feb 2015

Baxter Provides Update on Gene Therapy Program for Hemophilia B at EAHAD Annual Congress

Baxter International Inc. today provided an update on its gene therapy program, including progress on the Phase I/II open-label clinical trial assessing the safety and optimal dosing level of BAX 335, an investigational factor IX (FIX) gene therapy treatment for hemophilia B, during a sponsored symposium at the 8th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) in Helsinki, Finland.

13 Feb 2015

Novavax Commences Enrollment in Phase 1 Clinical Trial of Ebola GP Vaccine

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that enrollment has begun in a Phase 1 clinical trial of its Ebola virus glycoprotein (GP) recombinant nanoparticle vaccine candidate adjuvanted with Matrix-M™ (Ebola GP Vaccine) in healthy subjects.

From Novavax Inc. 13 Feb 2015

Researchers Demonstrate Biomedical Use of Gold Nanotubes in Mouse Model of Human Cancer

Scientists have shown that gold nanotubes have many applications in fighting cancer: internal nanoprobes for high-resolution imaging; drug delivery vehicles; and agents for destroying cancer cells.

13 Feb 2015

Nanostructured Porous Silicon for Chemotherapy Drug Delivery Behaves Differently in Cancerous Tumors

A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.

13 Feb 2015

FDA Grants NanoSmart Orphan Drug Designation for ANA-Conjugated Liposomal Doxorubicin

NanoSmart® Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration (FDA) for one of its lead candidates, antinuclear antibody (ANA) conjugated liposomal doxorubicin. The drug product is initially intended to treat Ewing's sarcoma, a rare type of cancer that develops in or around children's bones, with potential expansion into other indications.

12 Feb 2015

Heating Targeted Nano-Sized Drug Parcels Improves Delivery to Tumour Cells

Manchester scientists have found that gentle heating of targeted nano-sized drug parcels more effectively in deliver them to tumour cells – resulting in an improvement in survival rates.

12 Feb 2015

Nanomedicine News

Biodegradable Nano 'Drones' Could Prevent Heart Attacks Caused By Atherosclerosis

Antimicrobial Silver Nanoparticles Induce Stress in the Endoplasmic Reticulum, Demonstrating Nanotoxicity

Conventional Patch-Clamp Technique Combined with AFM Helps Record Activity of Moving Cells

NanoGap Sensor Device for Early Detection of Bladder and Kidney Cancer

Baxter Provides Update on Gene Therapy Program for Hemophilia B at EAHAD Annual Congress

Novavax Commences Enrollment in Phase 1 Clinical Trial of Ebola GP Vaccine

Researchers Demonstrate Biomedical Use of Gold Nanotubes in Mouse Model of Human Cancer

Nanostructured Porous Silicon for Chemotherapy Drug Delivery Behaves Differently in Cancerous Tumors

FDA Grants NanoSmart Orphan Drug Designation for ANA-Conjugated Liposomal Doxorubicin

Heating Targeted Nano-Sized Drug Parcels Improves Delivery to Tumour Cells

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting